Lyell Immunopharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
3.73 | 61.47 | -93.93% | -3.34 | -211.7% |
| P/S |
|
4112.26 | 33.58 | 12145.99% |
|
|
| P/BV |
|
0.8162 | 4.79 | -82.97% |
|
|
| P/FCF |
|
-3.38 | 60.06 | -105.63% |
|
|
| Ev/Ebitda |
|
-2.11 | -17.26 | -87.75% |
|
|
| Ev/S |
|
3477.8 | 22.49 | 15366.23% |
|
|
| Ev/FCF |
|
-2.72 | 67.63 | -104.02% |
|
|
| E/P |
|
-0.4173 | 0.0168 | -2577.72% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-164488.46 | 4.5 | -3658300.23% | -38530.56 | +326.9% |
| ROE |
|
-35.82 | 9.39 | -481.46% |
|
|
| ROA |
|
-31.28 | 0.1519 | -20691.19% |
|
|
| ROIC |
|
-78.68 | 7.63 | -1130.6% |
|
|
| ROS |
|
-180486.15 | -25.64 | 703805.79% |
|
|
| ROCE |
|
-35.74 | 15.19 | -335.35% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2954 | -3.68 | -91.97% | -0.3375 | -12.47% |
| Nеt Debt/Ebitda |
|
0.3857 | -4.07 | -109.49% |
|
|
| Debt/Ratio |
|
0.0842 | 0.199 | -57.68% |
|
|
| Debt/Equity |
|
0.097 | 1.67 | -94.18% |
|
|
| Debt/Net Income |
|
-0.2692 | 10.34 | -102.6% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-87 | 76.2 | -214.17% | ||
| Growth impulse Ebitda in 5 years |
|
124.96 | 44.75 | 179.24% | ||
| Growth impulse Net Income in 5 years |
|
81.89 | -15.36 | -633.14% | ||
| Growth impulse FCF in 5 years |
|
-823.39 | -9.39 | 8668.8% | ||
| Growth impulse EPS in 5 years |
|
43.82 | -84.03 | -152.15% |
IP Score
4.03/10
